China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHSE:600062) agreed to acquire 50.1% stake in Shenzhou Biology & Technology Co., Ltd from Aerospace Shenzhou Biology & Technology Group Co., Ltd , China Aerospace Investment Holdings Ltd , China Spacesat Co.,Ltd. (SHSE:600118) and Beijing Dawn Aerospace Bio-tech Co., Ltd. for approximately CNY 500 million on August 1, 2022.Aerospace Shenzhou Biology & Technology Co., Ltd holds 21.88% of Shenzhou Biology & Technology Co., Ltd., 16.33% of Shenzhou Biology & Technology Co., Ltd. held by Aerospace Investment Holdings Co., Ltd, 8.33% of Shenzhou Biology & Technology Co., Ltd. by China Spacesat Co.,Ltd., and 3.57% of Shenzhou Biology & Technology Co., Ltd. by Beijing Dawn Aerospace Bio-tech Co., Ltd. This has been approved in the 18th Meeting of the Company's 9th Directorate held on July 15, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
24.6 CNY | +1.65% | -0.40% | -4.73% |
Apr. 17 | China Spacesat's 2023 Profit Falls 45%, Operating Income Declines 17% | MT |
Apr. 16 | China Spacesat Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
24.6 CNY | +1.65% | -0.40% | 4.01B | ||
21.2 CNY | -0.84% | +0.66% | 2.99B | ||
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.73% | 4.01B | |
+18.74% | 35.01B | |
+56.97% | 4.72B | |
-4.61% | 2.23B | |
+17.32% | 1.39B | |
+2.12% | 885M | |
+176.03% | 808M | |
-50.40% | 557M | |
-4.91% | 433M | |
+62.84% | 401M |
- Stock Market
- Equities
- 600118 Stock
- News China Spacesat Co.,Ltd.
- China Resources Double-Crane Pharmaceutical Co.,Ltd. agreed to acquire 50.1% stake in Shenzhou Biology & Technology Co., Ltd. for approximately CNY 500 million.